Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will present a company overview at the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 16, 2022, at 1:00 p.m. ET. The live presentation will be accessible via the company's website under the 'News & Events' section and will be archived for about seven days.

Founded in 1990, Schrödinger's software platform accelerates drug and materials discovery, engaging with over 500 employees and customers in over 70 countries.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a company overview at the SVB Leerink Virtual 11th Annual Global Healthcare Conference. The live presentation will take place Wednesday, February 16, 2022, at 1:00 p.m. ET.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately seven days.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Twitter, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220208005047/en/

Jaren Irene Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Tracy Lessor

Schrödinger, Inc.

tracy.lessor@schrodinger.com

617-519-9827

Source: Schrödinger

FAQ

When will Schrödinger present at the SVB Leerink Global Healthcare Conference?

Schrödinger will present on February 16, 2022, at 1:00 p.m. ET.

How can I access Schrödinger's conference presentation?

The presentation can be accessed on Schrödinger's website in the 'News & Events' section.

What is the main focus of Schrödinger's technology?

Schrödinger focuses on transforming drug and materials discovery through a physics-based software platform.

How long will the presentation be available for viewing?

The presentation will be archived for approximately seven days.

What is Schrödinger's stock symbol?

Schrödinger's stock symbol is SDGR.